Commission Implementing Regulation (EU) No 201/2014 of 3 March 2014 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance tildipirosin Text with EEA relevance

• CELEX: Implementing Regulation (EU) No 201/2014
• Articles: 3

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

It shall apply from 3 May 2014.

Schedules & Appendices

ANNEX

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the substance tildipirosin is replaced by the following:

Pharmacologically active Substance

Marker residue

Animal Species

MRL

Target Tissues

Other Provisions (according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic classification

‘Tildipirosin

Tildipirosin

Bovine, caprine

400  μg/kg

Muscle

Not for use in animals from which milk is produced for human consumption.

Anti-infectious agents/Antibiotics’

200  μg/kg

Fat

2 000  μg/kg

Liver

3 000  μg/kg

Kidney

Porcine

1 200  μg/kg

Muscle

800  μg/kg

Skin and fat in natural proportions

5 000  μg/kg

Liver

10 000  μg/kg

Kidney